meta user
network profile
| bio | website | confounding.net |
|---|---|---|
| location | United States | |
| age | 29 | |
| visits | member for | 1 year, 5 months |
| seen | May 18 at 5:16 | |
| stats | profile views | 26 |
Infectious disease epidemiology doctoral student with a focus on the intersection of mathematical models of disease transmission and observational study methods - how observational studies can be used to parameterize models, and how models can help develop targets for observational study. Has a known, documented fondness for enteric pathogens.
Fluent in SAS, good enough in R, barely hanging on in Python and C.
Also the author of Confounded by Confounding, a blog of public health, statistics, and life as a graduate student.
Currently trying to get the 'Public Health and Epidemiology' SE site off the ground: http://area51.stackexchange.com/proposals/34565/public-health-epidemiology
|
Jan 4 |
comment |
Is it possible that the recipient of a heart transplant would display some of the donor's personality traits, as if the heart has memories? Alternately, they could be lied to about who their donor "was" to see if they manifest the memories and feelings of a 22 year old woman when their donor was actually a 35 year old man. Though I'm pretty sure an IRB would clobber that too. |
|
Jan 3 |
comment |
Are there people cured of HIV by means of HAART? @RoryM Indeed - a drug-based 'cure' for HIV is hardly a finding that would go under the radar. |
|
Dec 15 |
comment |
Vaccination and population dynamics of an epidemic Yes, that's correct. |
|
Dec 11 |
comment |
Vaccination and population dynamics of an epidemic You should ensure that the basic reproductive number for your Finland model is capable of sustaining an epidemic without vaccination. |
|
Sep 16 |
comment |
How is duration of efficacy estimated for vaccines? I've added some details to my answer. Your answer doesn't particularly conflict, its just asking about a subtly different process. |
|
Aug 23 |
comment |
Does making yogurt from non-pasteurized milk work against possible disease bacteria? @nico And you have not established that there are not. I pointed to a raw milk outbreak in Finland less than a month ago. There are others - your perception that they're aren't any doesn't necessarily mesh with reality. But foodborn outbreaks have to be very large to get much press, and raw milk products, even in Europe, aren't big enough to command that kind of attention. Also steak tartare has a very different pathogenic risk profile to hamburger meat ;) |
|
Aug 23 |
comment |
Does making yogurt from non-pasteurized milk work against possible disease bacteria? @nico As to the Slow Food page, while I have some issues with it overall, whether or not raw milk is good 'on the whole' was not the question - the question was whether raw milk yogurt would represent a new positive prevention for disease bacteria. I'd argue that the weight of the evidence for that is still firmly "no". |
|
Aug 23 |
comment |
Does making yogurt from non-pasteurized milk work against possible disease bacteria? @nico I very much doubt there's a genetic component - the time scale we're talking about between the divergence from raw milk to widespread pasteurization is quite short. Odds are that people in France simply accept the risk, in the same way people in the U.S. accept the risk of say, medium/medium-rare hamburger. |
|
Aug 23 |
comment |
Does making yogurt from non-pasteurized milk work against possible disease bacteria? @nico Added information and some nuance to the answer. It's a "staggering proportion" given the volume of raw milk consumed in this country. I suspect the same is true for the great part of Europe - people eat food that will give them food-born illness all the time. Unless its a massive outbreak in a popular food item, you won't hear about it. |
|
Aug 11 |
comment |
What is the difference between naive and adjusted p-values in a GWAS study? I suspect one of the reasons to report the unadjusted value is, as I allude to in my answer, many papers are now simply using a non-0.05 cutoff point instead of using some sort of multiple comparisons adjustment (which have their own issues). The unadjusted answer allows for comparison with those studies - I don't actually think its a red herring. |
|
Aug 11 |
comment |
What is the difference between naive and adjusted p-values in a GWAS study? Please consider accepting some of the answers to your previous questions. |
|
Mar 12 |
comment |
How does herpes (HSV) infection suppress HIV? Also, can we have a citation on this claim? Most of what I've seen suggests that HSV-2 is a risk factor for the acquisition of HIV, and that is is the suppression of HSV using acyclovir that helps prevent HIV. |
|
Mar 12 |
comment |
How does herpes (HSV) infection suppress HIV? @bobthejoe I don't think it is. For example, HSV-1 and HSV-2 are massively different infections, and both are extremely common in humans. |
|
Mar 6 |
comment |
How are antibiotic resistant bacterial infections treated? A second vote for reopening. The question is not "What drugs should I use to treat X", the question is how they are treated. That question is very much in the domain of microbiology and epidemiology, neither one of which are medical fields. |
|
Jan 18 |
comment |
If a human takes antibiotics are all bacteria in the body killed? Bloody autocorrect on the new OS grumble |
|
Jan 10 |
comment |
Why is the microbial ecosystem of the gut so susceptible to disruption by pathogens? Keep in mind one of the most common harmful species is a native species in many people: Clostridium difficile. |
|
Dec 31 |
comment |
What is the most difficult feature to explain evolutionarily? @KonradRudolph I work on some of those models, and they're less than "quite easy", especially when multiple pathogens are pulled into the equation, or you start working on multiple scales. |
|
Dec 17 |
comment |
Are there animal models for Clostridium difficile that better replicate human infection than hamsters? I have now - thanks |
